α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population

Chest

Volumn 143, Issue 4, 2013, Pages 1000-1008

  Bornhorst, Joshua A ^a   Greene, Dina N ^b   Ashwood, Edward R ^c,d   Grenache, David G ^c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHILD; CLINICAL RESEARCH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ELECTROPHORESIS; FEMALE; GENDER; GENE FREQUENCY; HETEROZYGOSITY; HUMAN; INFANT; ISOELECTRIC FOCUSING; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

EID: 84875970525     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0564     Document Type: Article

References (50)

1. Crystal RG. The alpha 1-antitrypsin gene and its deficiency states. Trends Genet. 1989; 5 (12): 411-417.
2. Aboussouan LS, Stoller JK. Detection of alpha-1 antitrypsin deficiency: a review. Respir Med. 2009; 103 (3): 335-341.
3. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005; 365 (9478): 2225-2236.
4. Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: clinical manifestations and natural history. Thorax. 2004; 59 (5): 441-445.
5. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985; 1 (8421): 152- 154.
6. Fairbanks KD, Tavill AS. Liver disease in alpha 1-antitrypsin deficiency: a review. Am J Gastroenterol. 2008; 103 (8): 2136-2141.
7. de Serres FJ. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect. 2003; 111 (16): 1851-1854.
8. de Serres FJ, Blanco I, Fernández-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet. 2003; 64 (5): 382-397.
9. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004; 59 (2): 164-169.
10. Silverman EK, Miletich JP, Pierce JA, et al. Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis. 1989; 140 (4): 961-966
11. Massi G, Cotumaccia R, Auconi P, Patriarchi P, Mirabella A, Rizzo G. Alpha 1-antitrypsin PiM subtypes and chronic obstructive pulmonary disease (COPD). Chest. 1982; 82 (4): 513.
12. . DeMeo DL, Silverman EK. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax . 2004; 59 (3): 259-264.
13. Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012; 185 (3): 246-259.
14. Turino GM, Barker AF, Brantly ML, et al. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1996; 154 (6 pt 1): 1718-1725.
15. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med. 2002; 136 (4): 270-279.
16. Dahl M, Hersh CP, Ly NP, Berkey CS, Silverman EK, Nordestgaard BG. The protease inhibitor PIS allele and COPD: a meta-analysis. Eur Respir J. 2005; 26 (1): 67-76.
17. Yang P, Sun Z, Krowka MJ, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008; 168(10): 1097-1103.
18. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997; 75 (5): 397-415.
19. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005; 128 (4): 1989-1994.
20. Jain A, McCarthy K, Xu M, Stoller JK. Impact of a clinical decision support system in an electronic health record to enhance detection of α1 -antitrypsin deficiency. Chest. 2011; 140 (1): 198-204.
21. Sveger T, Thelin T. A future for neonatal alpha1-antitrypsin screening? Acta Paediatr. 2000; 89 (3): 259-261.
22. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med. 2007; 101 (8): 1708-1714.
23. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest. 2005; 128(3): 1179- 1186.
24. Stoller JK, Snider GL, Brantly ML, et al American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency [in German]. Pneumologie. 2005; 59(1): 36- 68.
25. Brantly M. Efficient and accurate approaches to the laboratory diagnosis of alpha1-antitrypsin deficiency: The promise of early diagnosis and intervention. Clin Chem. 2006; 52 (12): 2180-2181.
26. Righetti PG, Gianazza E, Bianchi-Bosisio A, Sinha P, Köttgen E. Isoelectric focusing in immobilized pH gradients: applications in clinical chemistry and forensic analysis. J Chromatogr A. 1991; 569 (1-2): 197-228.
27. Gorrini M, Ferrarotti I, Lupi A, et al. Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. Clin Chem. 2006; 52 (5): 899-901.
28. Aslanidis C, Nauck M, Schmitz G. High-speed detection of the two common alpha(1)-antitrypsin deficiency alleles Pi&z.ast;Z and Pi&z.ast;S by real-time fluorescence PCR and melting curves. Clin Chem. 1999; 45 (10): 1872-1875.
29. Chen Y, Snyder MR, Zhu Y, et al. Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatographytandem mass spectrometry. Clin Chem. 2011; 57(8): 1161- 1168.
30. Snyder MR, Katzmann JA, Butz ML, et al. Diagnosis of alpha-1-antitrypsin deficiency: an algorithm of quantification, genotyping, and phenotyping. Clin Chem. 2006; 52 (12): 2236-2242.
31. Bornhorst JA, Procter M, Meadows C, Ashwood ER, Mao R. Evaluation of an integrative diagnostic algorithm for the identification of people at risk for alpha1-antitrypsin deficiency. Am J Clin Pathol. 2007; 128 (3): 482-490.
32. Steiner SJ, Gupta SK, Croffie JM, Fitzgerald JF. Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene. Dig Dis Sci. 2003; 48 (9): 1793-1796.
33. Corda L, Bertella E, Pini L, et al. Diagnostic flow chart for targeted detection of alpha1-antitrypsin deficiency. Respir Med. 2006; 100 (3): 463-470.
34. Lisowska-Myjak B. AAT as a diagnostic tool. Clin Chim Acta. 2005; 352 (1-2): 1-13.
35. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature. J Clin Lab Anal. 2000; 14 (6): 265-270.
36. Cook L, Burdon JG, Brenton S, Knight KR, Janus ED. Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology. 1996; 28 (3): 242-247.
37. Crystal RG, Brantly ML, Hubbard RC, Curiel DT, States DJ, Holmes MD. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest. 1989; 95 (1): 196-208.
38. Faber JP, Poller W, Weidinger S, et al. Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI&z.ast;Q0 alleles and one deficient PI&z.ast;M allele. Am J Hum Genet. 1994; 55 (6): 1113-1121.
39. Milman N, Graudal N, Andersen HC. Acute phase reactants in the elderly. Clin Chim Acta. 1988; 176 (1): 59-62.
40. Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, Crystal RG. Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest. 1991; 100 (3): 703-708.
41. McGee D, Schwarz L, McClure R, et al. Is PiSS alpha-1 antitrypsin deficiency associated with disease? Pulm Med. 2010 ; 2010 : 570679.
42. Eriksson S, Lindell SE, Wiberg R. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. Eur J Respir Dis. 1985; 67 (4): 279-285.
43. Bornhorst JA, Calderon FR, Procter M, Tang W, Ashwood ER, Mao R. Genotypes and serum concentrations of human alpha- 1-antitrypsin "P" protein variants in a clinical population. J Clin Pathol. 2007; 60 (10): 1124-1128.
44. Lomas DA, Parfrey H. Alpha1-antitrypsin deficiency. 4: molecular pathophysiology. Thorax. 2004; 59 (6): 529-535.
45. Sifers RN. Intracellular processing of alpha1-antitrypsin. Proc Am Thorac Soc. 2010; 7 (6): 376-380.
46. Ogushi F, Fells GA, Hubbard RC, Straus SD, Crystal RG. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest. 1987; 80 (5): 1366-1374.
47. Roche D, Mesner A, Al Nakib M, Leonard F, Beaune P. Automated determination of serum alpha1-antitrypsin by antitryptic activity measurement. Clin Chem. 2009; 55 (3): 513-518.
48. Sandford AJ, Chagani T, Spinelli JJ, Paré PD. alpha1-antitrypsin genotypes and the acute-phase response to open heart surgery. Am J Respir Crit Care Med. 1999; 159 (5 pt 1): 1624-1628.
49. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med. 1999; 160 (6): 1968-1975.
50. Stoller JK, Fromer L, Brantly M, Stocks J, Strange C. Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve Clin J Med. 2007; 74 (12): 869-874.